PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21208554-9	2011	Pretreatment with antioxidants such as N-acetylcysteine and diphenyleneiodonium significantly inhibited the activation of p38 MAPK compared with LPS control (P<0.05).	diphenyleneiodonium	60-79	mitogen activated protein kinase 14	Rattus norvegicus	122-125	
17308014-11	2007	DPI and DETC blocked RI-induced p38 MAP kinase activation in response to vascular endothelial growth factor and RI.	diphenyleneiodonium	0-3	mitogen activated protein kinase 14	Rattus norvegicus	32-35	
11006268-13	2000	Diphenylene iodonium, a potent inhibitor of NADPH oxidase(s), and ascorbic acid, an effective free radical scavenger, suppressed TSH- or forskolin-stimulated p38-MAPK phosphorylation, indicating that the generation of reactive oxygen species plays a key role in signaling from cAMP to p38-MAPKs.	diphenyleneiodonium	0-20	mitogen activated protein kinase 14	Rattus norvegicus	158-161	
11006268-13	2000	Diphenylene iodonium, a potent inhibitor of NADPH oxidase(s), and ascorbic acid, an effective free radical scavenger, suppressed TSH- or forskolin-stimulated p38-MAPK phosphorylation, indicating that the generation of reactive oxygen species plays a key role in signaling from cAMP to p38-MAPKs.	diphenyleneiodonium	0-20	mitogen activated protein kinase 14	Rattus norvegicus	285-294	
15743761-2	2005	Among three MAPKs, c-Jun NH(2)-terminal kinase (JNK) and p38 MAPK required ROS production for activation, as an NADPH oxidase inhibitor, diphenyleneiodonium, inhibited the activation.	diphenyleneiodonium	137-156	mitogen activated protein kinase 14	Rattus norvegicus	57-60	
15743761-4	2005	Constitutively active Galpha(12)- or Galpha(13)-induced activation of JNK and p38 MAPK, but not extracellular signal-regulated kinase (ERK), was inhibited by diphenyleneiodonium.	diphenyleneiodonium	158-177	mitogen activated protein kinase 14	Rattus norvegicus	78-81	
19762685-5	2009	Oxidative stress induced by microinjection of angiotensin II into RVLM augmented UCP2 mRNA or protein expression in RVLM, which was antagonized by comicroinjection of NADPH oxidase inhibitor (diphenyleneiodonium chloride), superoxide dismutase mimetic (tempol), or p38 mitogen-activated protein kinase inhibitor (SB203580) but not by extracellular signal-regulated kinase 1/2 inhibitor (U0126).	diphenyleneiodonium	192-220	mitogen activated protein kinase 14	Rattus norvegicus	265-268